Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Endocrine 1CNS 1

Conditions

Brain Neoplasms 286Glioblastoma 259Glioma 202Neuroblastoma 86Neoplasms 61Astrocytoma 55Central Nervous System Neoplasms 53Medulloblastoma 46Breast Neoplasms 43Sarcoma 39Meningioma 39Melanoma 39Carcinoma, Non-Small-Cell Lung 39Neurofibromatosis 1 38Ependymoma 36Lung Neoplasms 35Osteosarcoma 31Rhabdomyosarcoma 30Sarcoma, Ewing 28Neoplasm Metastasis 28Diffuse Intrinsic Pontine Glioma 28Rhabdoid Tumor 27Recurrence 26Oligodendroglioma 23Wilms Tumor 21Gliosarcoma 21Pheochromocytoma 20Pancreatic Neoplasms 20Hepatoblastoma 20Thyroid Neoplasms 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lewy Body Disease × CNS × 90 days × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡